Anti-VEGF Antibody Protects against Alveolar Exudate Leakage Caused by Vascular Hyperpermeability, Resulting in Mitigation of Pneumonitis Induced by Immunotherapy

Immune-related pneumonitis is an important toxicity associated with checkpoint inhibitor therapy with anti–PD-1 or anti–PD-L1 antibodies, often necessitating discontinuation of treatment. Development of methods to mitigate checkpoint inhibitor–related pneumonitis is required. The contributions of PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwai, Toshiki, Sugimoto, Masamichi, Patel, Hina, Yorozu, Keigo, Kurasawa, Mitsue, Kondoh, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Large Molecule Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306403/
https://www.ncbi.nlm.nih.gov/pubmed/34552009
http://dx.doi.org/10.1158/1535-7163.MCT-21-0031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306403/
https://www.ncbi.nlm.nih.gov/pubmed/34552009
http://dx.doi.org/10.1158/1535-7163.MCT-21-0031

Ejemplares similares